Abstract
Brigatinib (ALUNBRIG (TM)) is a small molecule antineoplastic anaplastic lymphoma kinase (ALK) inhibitor being developed by ARIAD Pharmaceuticals (a w......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
